John Vavricka

Business address
C/O Atea Pharmaceuticals, Inc., 125 Summer Street, Boston, MA, 02110
Top holdings (ownership)
AVIR
Get insider transactions for this reporting owner
John Vavricka has filed 8 SEC EDGAR filings since 29 Oct 2020

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing 4 04 Feb 2025 31 Jan 2025 001-39661
4 Open Document Open Filing 4 02 Feb 2024 31 Jan 2024 001-39661
144 Open Document Open Filing 01 Feb 2024
4 Open Document Open Filing FORM 4 SUBMISSION 02 Feb 2023 31 Jan 2023 001-39661
4 Open Document Open Filing FORM 4 SUBMISSION 02 Feb 2022 31 Jan 2022 001-39661
4 Open Document Open Filing FORM 4 SUBMISSION 01 Feb 2021 29 Jan 2021 001-39661
4 Open Document Open Filing FORM 4 SUBMISSION 03 Nov 2020 03 Nov 2020 001-39661
3 Open Document Open Filing FORM 3 SUBMISSION 29 Oct 2020 29 Oct 2020 001-39661